Medtronic Net Income 2006-2018 | MDT

Medtronic annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Medtronic net income for the quarter ending October 31, 2018 was $1.115B, a 44.72% decline year-over-year.
  • Medtronic net income for the twelve months ending October 31, 2018 was $2.261B, a 54.93% decline year-over-year.
  • Medtronic annual net income for 2018 was $3.104B, a 22.94% decline from 2017.
  • Medtronic annual net income for 2017 was $4.028B, a 13.85% increase from 2016.
  • Medtronic annual net income for 2016 was $3.538B, a 32.26% increase from 2015.
Medtronic Annual Net Income
(Millions of US $)
2018 $3,104
2017 $4,028
2016 $3,538
2015 $2,675
2014 $3,065
2013 $3,467
2012 $3,617
2011 $3,096
2010 $3,099
2009 $2,070
2008 $2,138
2007 $2,802
2006 $2,547
2005 $1,804
Medtronic Quarterly Net Income
(Millions of US $)
Q2 2018 $1,115
Q1 2018 $1,075
Q4 2018 $1,460
Q3 2018 $-1,389
Q2 2017 $2,017
Q1 2017 $1,016
Q4 2017 $1,163
Q3 2017 $821
Q2 2016 $1,115
Q1 2016 $929
Q4 2016 $1,103
Q3 2016 $1,095
Q2 2015 $520
Q1 2015 $820
Q4 2015 $-1
Q3 2015 $977
Q2 2014 $828
Q1 2014 $871
Q4 2014 $448
Q3 2014 $762
Q2 2013 $902
Q1 2013 $953
Q4 2013 $969
Q3 2013 $988
Q2 2012 $646
Q1 2012 $864
Q4 2012 $990
Q3 2012 $935
Q2 2011 $871
Q1 2011 $821
Q4 2011 $776
Q3 2011 $924
Q2 2010 $566
Q1 2010 $830
Q4 2010 $955
Q3 2010 $831
Q2 2009 $868
Q1 2009 $445
Q4 2009 $102
Q3 2009 $698
Q2 2008 $547
Q1 2008 $723
Q4 2008 $720
Q3 2008 $77
Q2 2007 $666
Q1 2007 $675
Q4 2007 $812
Q3 2007 $710
Q2 2006 $681
Q1 2006 $599
Q4 2006 $739
Q3 2006 $670
Q2 2005 $817
Q1 2005 $321
Q4 2005 $195
Q3 2005 $544
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $126.569B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $122.855B 24.89
Stryker (SYK) United States $63.182B 23.82
Boston Scientific (BSX) United States $49.097B 24.81
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $22.421B 14.54
Smith & Nephew SNATS (SNN) United Kingdom $16.589B 0.00
ResMed (RMD) United States $15.674B 29.89
Perrigo (PRGO) Ireland $8.142B 12.36
Bio-Rad Laboratories (BIO) United States $7.677B 49.09
Canopy Growth (CGC) Canada $7.290B 0.00
Hill-Rom Holdings (HRC) United States $6.241B 19.53
Aurora Cannabis (ACB) Canada $5.730B 30.26
Haemonetics (HAE) United States $5.332B 46.90
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.752B 26.48
Hutchison China MediTech (HCM) China $4.204B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.765B 0.00
Neogen (NEOG) United States $3.198B 48.43
Agios Pharmaceuticals (AGIO) United States $3.093B 0.00
NuVasive (NUVA) United States $2.886B 26.85
National Vision Holdings (EYE) United States $2.497B 48.30
NxStage Medical (NXTM) United States $1.925B 0.00
Quidel (QDEL) United States $1.917B 24.99
Phibro Animal Health (PAHC) United States $1.327B 18.78
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.204B 0.00
Cardiovascular Systems (CSII) United States $0.991B 1428.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.886B 22.96
Meridian Bioscience (VIVO) United States $0.778B 24.80
Surmodics (SRDX) United States $0.766B 116.65
OraSure Technologies (OSUR) United States $0.752B 42.35
Cerus (CERS) United States $0.726B 0.00
MacroGenics (MGNX) United States $0.693B 0.00
Omeros (OMER) United States $0.687B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.00
Lantheus Holdings (LNTH) United States $0.652B 20.17
NanoString Technologies (NSTG) United States $0.527B 0.00
LeMaitre Vascular (LMAT) United States $0.502B 24.65
Owens & Minor (OMI) United States $0.433B 4.90
Quanterix (QTRX) United States $0.433B 0.00
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.385B 0.00
Evolus (EOLS) United States $0.375B 0.00
VAPOTHERM INC (VAPO) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.90
Cytosorbents (CTSO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.207B 279.25
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.135B 6.77
Imprimis Pharmaceuticals (IMMY) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.079B 16.53
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.27
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.052B 0.00
Neurotrope (NTRP) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00